| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 49.60M | — |
| Operating expense | — | — |
| Net income | -972.00K | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PMRA.F returned +3.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +13.2% |
| 1 year | +3.9% |
| 5 years | +22.0% |
| 10 years | +154.8% |
| All-time high | €268.80 (Oct 2000) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in PMRA.F would be worth today ›Yes. Pharma Mar, S.A. paid 1 dividend over the past 12 months. The most recent was €1.00 per share on Jul 8, 2026. The dividend yield is 1.19%.
Pharma Mar, S.A. is part of the Healthcare sector.
Pharma Mar, S.A. has a market cap of 1.43B EUR, based on the latest quote.
Pharma Mar, S.A. is expected to report earnings around Oct 29, 2026. That date is an estimate and has not been confirmed by the company.
